{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "HBM HLDGS LTD  DL-,000025", "longName": "HBM Holdings Limited", "messageBoardId": "finmb_693912695", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 2.1052675, "regularMarketPrice": 0.194, "marketState": "REGULAR", "sharesOutstanding": 744323008, "bookValue": 0.128, "fiftyDayAverage": 0.23784, "fiftyDayAverageChange": -0.04383999, "fiftyDayAverageChangePercent": -0.18432556, "twoHundredDayAverage": 0.26453, "twoHundredDayAverageChange": -0.07053, "twoHundredDayAverageChangePercent": -0.26662382, "marketCap": 170462368, "priceToBook": 1.515625, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1612335600000, "priceHint": 4, "regularMarketChange": 0.004000008, "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.194, "regularMarketDayRange": "0.194 - 0.194", "regularMarketDayLow": 0.194, "regularMarketVolume": 1605, "regularMarketPreviousClose": 0.19, "bid": 0.196, "ask": 0.258, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.194, "averageDailyVolume3Month": 27, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.044, "fiftyTwoWeekLowChangePercent": 0.29333332, "fiftyTwoWeekRange": "0.15 - 0.496", "fiftyTwoWeekHighChange": -0.302, "fiftyTwoWeekHighChangePercent": -0.6088709, "fiftyTwoWeekLow": 0.15, "fiftyTwoWeekHigh": 0.496, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.17, "symbol": "6XY.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Tower A, 12th Floor", "address2": "Fenglin International Plaza Phase II 420 Fenglin Road Xuhui District", "city": "Shanghai", "zip": "200032", "country": "China", "phone": "86 21 5339 9123", "website": "https://www.harbourbiomed.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "HBM Holdings Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. It is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor; Tanfanercept (HBM9036) to treat moderate to-severe dry eye disease; HBM7008, a bispecific antibody targeting tumor Associated antigen; and HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4. The company is also developing HBM9022 for the treatment of SARS-COV-2; HBM9302 for the treatment of breast and gastric cancers; HBM7020 for the treatment of multiple myeloma; and HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022 for the treatment of solid tumors. It operates in Mainland China, the United States, Europe, and internationally. The company has collaboration on antibody-drug conjugate projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was incorporated in 2016 and is based in Shanghai, the People's Republic of China.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Jingsong  Wang M.D., Ph.D.", "age": 57, "title": "Founder, Chairman & CEO", "yearBorn": 1965, "fiscalYear": 2021, "totalPay": {"raw": 13267000, "fmt": "13.27M", "longFmt": "13,267,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Weihao  Xu", "age": 39, "title": "CFO, Chief Bus. Officer and Global Head of Bus. & Corp. Devel.", "yearBorn": 1983, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yiping  Rong Ph.D.", "age": 45, "title": "Chief Scientific Officer & Exec. Director", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bruce  Zhang", "title": "Head of Legal", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peter F. Moesta Ph.D.", "title": "Member of Scientific Advisory Board & Chief CMC Advisor", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Humphrey A. R. Gardner FCAP, M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Xiaolu  Tao", "age": 48, "title": "Chief Devel. Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wing Yat  Lui", "age": 32, "title": "Joint Company Sec.", "yearBorn": 1990, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yu  Fu", "age": 31, "title": "Joint Company Sec.", "yearBorn": 1991, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}